ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1102

Na/K-ATPase Signaling as an Amplifier of Oxidative Stress Contributes to the Increased Salt Sensitivity of Obese Hypertension

Session Information

  • Salt and Hypertension
    November 04, 2017 | Location: Hall H, Morial Convention Center
    Abstract Time: 10:00 AM - 10:00 AM

Category: Hypertension

  • 1102 Hypertension: Basic and Experimental - Renal Causes and Consequences

Authors

  • Yan, Yanling, Marshall University School of Medicine, Huntington, West Virginia, United States
  • Chaudhry, Muhammad A., Marshall University School of Medicine, Huntington, West Virginia, United States
  • Nie, Ying, Marshall University School of Medicine, Huntington, West Virginia, United States
  • Kim, Jung Han, Marshall University School of Medicine, Huntington, West Virginia, United States
  • Xie, Zi-jian, Marshall University School of Medicine, Huntington, West Virginia, United States
  • Shapiro, Joseph I., Marshall University School of Medicine, Huntington, West Virginia, United States
  • Liu, Jiang, Marshall University School of Medicine, Huntington, West Virginia, United States
Background

Na/K-ATPase acts as a receptor for reactive oxygen species (ROS) and amplifies ROS signaling, regulating renal sodium excretion (JBC, 2011&2013; JAHA, 2016). Whether or not these pathways are involved in the pathogenesis of obese hypertension due to impaired Na/K-ATPase signaling has not been investigated.

Methods

Blood pressures were measured using the tail-cuff method. Na/K-ATPase signaling activation was assessed in the kidney cortex from high fat (HF)-induced obese C57BL/6J (B6) mice, polygenic obese TALLYHO/JngJ (TH) mice and obese Zucker rats by measuring the phosphorylation of c-Src and ERK1/2 by Western blot. Protein carbonylation (DNP) and heme oxygenase 1 (HO-1) as a commonly used marker for oxidative stress were used to measure the levels of ROS. Renal function curve was constructed with high salt diets (HS, 2, 4, and 8% NaCl).

Results

In the kidney cortex tissue, the Na/K-ATPase signaling (c-Src and ERK1/2 phosphorylation) and oxidative stress (protein carbonylation and HO-1) were activated and were not stimulated by HS diets in obese TH mice (comparing to B6 mice, Figure A, left panel). Moreover, in salt-loading experiments (with 2, 4, and 8% NaCl), we demonstrated that obese TH mice exhibited an increased salt sensitivity of blood pressure, characterized by a right-shifted, reduced slope in renal function curve (Figure A, right panel, p<0.01). We also observed had a higher baseline oxidative stress and Na/K-ATPase activation in Obese Zucker rats (comparing to lean Zucker rats, Figure B) and high fat-induced obese B6 mice.

Conclusion

Na/K-ATPase signaling activation as a commonly featured characteristic in obese mice and rat was implicated in the increased salt sensitivity of obese hypertension. Further studies targeting Na/K-ATPase signaling will explore the potential nodes for therapeutic intervention and precise target localization to render the required pharmacologic therapy more effective, minimizing the need for medications.